Success Metrics

Completion Rate

0%(0/1)

Active Trials

1(33%)

Terminated

1(33%)

Phase Distribution

Ph phase_3

33%

Ph phase_1

33%

Ph not_applicable

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

Phase 3Large-scale testing

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Terminated(1)

Other(1)

Detailed Status

Terminated1

unknown1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

0.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (33.3%)

Phase 31 (33.3%)

N/A1 (33.3%)

Trials by Status

terminated133%

unknown133%

recruiting133%

Recent Activity

1 active trials

Showing 3 of 3

recruitingphase_1

Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgeries With Cardiopulmonary Bypass

NCT06917859

unknownphase_3

Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab

NCT05002517

terminatednot_applicable

Platelet-rich Plasma (PRP) Injection for Treating Shoulder Subacromial Impingement Syndrome

NCT02669303

Clinical Trials (3)

Showing 3 of 3 trials

NCT06917859Phase 1

Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgeries With Cardiopulmonary Bypass

Recruiting

NCT05002517Phase 3

Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab

Unknown

NCT02669303Not Applicable

Platelet-rich Plasma (PRP) Injection for Treating Shoulder Subacromial Impingement Syndrome

Terminated

All 3 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 3